Loading Events

« All Events

BE Seminar: “Precision Engineering for Cancer Immunotherapy” (James Moon, University of Michigan)

November 10 at 3:30 PM - 4:30 PM

This is a hybrid seminar which will be held in Glandt Forum (Singh Center) and via Zoom (link coming soon).

Precision Engineering for Cancer Immunotherapy

Cancer immunotherapy is now considered the fourth pillar of cancer therapy, joining the ranks of surgery, radiotherapy, and chemotherapy. However, only a small subset of cancer patients responds to cancer immunotherapy. Thus, new approaches are needed to amplify anti-tumor immunity, to convert cold tumor into hot tumor, and to potentiate immunotherapies with minimal immune-related adverse events. The gut microbiome has recently emerged as the next frontier in drug development; however, it remains unclear how to effectively alter gut microbiota for treating various diseases, including cancer. Here, we present new biomaterial-based strategies for altering the gut microbiome and improving the safety and efficacy of cancer immunotherapy. We are developing new dietary fiber-based biomaterials for in situ modulation of the gut microbiome for augmenting local and systemic immune responses. We will present the therapeutic potential of our gut modulation approach in the context of improving the efficacy of immune checkpoint blockers while mitigating immune-related adverse events. In our second research thrust, we are developing a new nanoparticle platform for systemic delivery of STING (stimulator of IFN genes) agonists. While local STING activation can convert cold tumor into hot tumor, it has been challenging to develop STING agonists that can treat disseminated cancer due to their toxicity. Here, we will present our next-generation STING agonists that allow for systemic cancer therapy with potent efficacy, favorable pharmaceutical properties, and acceptable safety profiles in various murine and rabbit tumor models. Our biomaterial-based strategies may offer powerful and convenient approaches to regulate the immune system as potential therapies for cancer and other diseases.

James J. Moon, Ph.D.

J.G. Searle Professor, Departments of Pharmaceutical Sciences, Biomedical Engineering, and Chemical Engineering; BioInterfaces Institute; University of Michigan

Dr. James Moon is John Gideon Searle Professor in the Department of Pharmaceutical Sciences, Biomedical Engineering, and Chemical Engineering at the University of Michigan, Ann Arbor. His interdisciplinary research program aims to develop novel biomaterials-based strategies to advance fundamental understanding of the immune system, with the ultimate goal of improving patients’ lives with effective vaccines and immunotherapies. Dr. Moon has published over 100 research articles, including those published in Nature Materials, Nature Medicine, Nature Nanotechnology, Nature Biomedical Engineering, Nature Reviews Materials, and Science Translational Medicine. He has over 20 pending/approved U.S. and international patent applications, and his novel nano-vaccine delivery technologies have led to 3 new start-up companies (EVOQ Therapeutics, Saros Therapeutics, and Elicio Therapeutics). Dr. Moon contribution to the field has been recognized with numerous awards, including AAPS Emerging Leader Award, NSF CAREER Award, and DOD-CDMRP Career Development Award. Dr. Moon received his bachelor’s degree from the University of California, Berkeley, and his Ph.D. from Rice University, and he completed his postdoctoral training at MIT.

Details

Date:
November 10
Time:
3:30 PM - 4:30 PM
Event Category:
Event Tags:
,

Organizer

Bioengineering
Phone:
215-898-8501
Email:
be@seas.upenn.edu
View Organizer Website

Venue

Glandt Forum, Singh Center for Nanotechnology
3205 Walnut Street
Philadelphia, PA 19104 United States
+ Google Map
View Venue Website